ResMed Inc (RMD)

Cash ratio

Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021 Jun 30, 2020
Cash and cash equivalents US$ in thousands 238,361 227,891 273,710 295,278 463,156
Short-term investments US$ in thousands 12,026 12,423 9,167
Total current liabilities US$ in thousands 910,655 758,533 689,299 911,766 602,761
Cash ratio 0.27 0.32 0.41 0.32 0.77

June 30, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($238,361K + $12,026K) ÷ $910,655K
= 0.27

The cash ratio of ResMed Inc has shown a gradual decline over the past five years, decreasing from 0.77 in 2020 to 0.27 in 2024. This indicates a decreasing ability of the company to cover its short-term liabilities with its available cash and cash equivalents.

A cash ratio below 1 suggests that ResMed Inc may not have enough liquid assets to meet its current obligations if they were all to become due immediately. The downward trend in the cash ratio may indicate potential liquidity concerns or inefficiencies in managing cash resources.

It is important for ResMed Inc to closely monitor its cash position and liquidity management strategies to ensure it can meet its short-term financial obligations and maintain financial stability. Additional analysis of other liquidity ratios and cash flow metrics would provide a more comprehensive view of the company's overall liquidity position.


Peer comparison

Jun 30, 2024